Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

PaperCitations, authors & open-access status

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,062 citations, 2018 year and bronze oa status.

1,062
Citations
2018
Year
bronze
OA Status

Related on ScholarIQ

Ann Marie Hake
Author
Bruno Vellas
Author
New England Journal of Medicine
Journal
Alzheimer's disease research and treatments
Topic
Alzheimer's disease research and treatments
Topic
Dementia and Cognitive Impairment Research
Topic
470M+ articles · free account